You are using an outdated browser. Please upgrade your browser to improve your experience.

fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description Combined oxidative phosphorylation deficiency type 3 is an extremely rare clinically heterogenous disorder described in about 5 patients to date. Clinical signs included hypotonia, lactic acidosis, and hepatic insufficiency, with progressive encephalomyopathy or hypertrophic cardiomyopathy.
Uniprot Description A mitochondrial disease resulting in severe metabolic acidosis with encephalomyopathy or with hypertrophic cardiomyopathy. Patients show a severe defect in mitochondrial translation leading to a failure to assemble adequate amounts of three of the oxidative phosphorylation complexes.
Mondo Term and Equivalent IDs
MONDO:0012512:  fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
DOID:0111486: 
MESH:C566467: 
Orphanet:168566: 
SCTID:720951008: